{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:21:51Z","timestamp":1792686111091,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005362","name":"Universita degli Studi di Bari Aldo Moro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004702","name":"Universit\u00e0 degli Studi di Genova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013175","name":"European Society for Clinical Investigation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019637","name":"Horizon Therapeutics","doi-asserted-by":"publisher","award":["101080329"],"award-info":[{"award-number":["101080329"]}],"id":[{"id":"10.13039\/100019637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PE0000003"],"award-info":[{"award-number":["PE0000003"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["1550"],"award-info":[{"award-number":["1550"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030902","name":"Martin-Luther-Universit\u00e4t Halle-Wittenberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030902","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017249","name":"Universit\u00e9 Monastir","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032208","name":"Centre Tecnol\u00f2gic de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032208","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004113","name":"Universit\u00e9 Libanaise","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004113","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004462","name":"Consiglio Nazionale delle Ricerche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004462","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["CUP D93C22000890001"],"award-info":[{"award-number":["CUP D93C22000890001"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejim.2025.05.018","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:29:51Z","timestamp":1748359791000},"page":"101-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Metabolic dysfunction-associated steatotic liver disease (MASLD). Assessing metabolic dysfunction, cardiovascular risk factors, and lifestyle habits"],"prefix":"10.1016","volume":"138","author":[{"given":"Hala","family":"Abdallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Awada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-7376","authenticated-orcid":false,"given":"Agostino","family":"Di Ciaula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-1471","authenticated-orcid":false,"given":"Piero","family":"Portincasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2025.05.018_bib0001","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0002","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.07.030","article-title":"Association of hepatic steatosis with major adverse cardiovascular events, independent of coronary artery disease","volume":"19","author":"Meyersohn","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0004","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2306192","article-title":"The association of metabolic dysfunction-associated steatotic liver disease (MASLD) with the risk of myocardial infarction: a systematic review and meta-analysis","volume":"56","author":"Lv","year":"2024","journal-title":"Ann Med"},{"key":"10.1016\/j.ejim.2025.05.018_bib0005","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16060942","article-title":"The Mediterranean diet: from an environment-driven food culture to an emerging medical prescription","volume":"16","author":"Lacatusu","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ejim.2025.05.018_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/nu14183771","article-title":"Association between Mediterranean diet and fatty liver in women with overweight and obesity","volume":"14","author":"Leone","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ejim.2025.05.018_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073071","article-title":"Chronic inflammatory diseases and cardiovascular risk: current insights and future strategies for optimal management","volume":"26","author":"Cacciatore","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejim.2025.05.018_bib0009","article-title":"Ten-year cardiovascular risk among cancer survivors: the National Health and Nutrition Examination Survey","volume":"16","author":"Zhang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2025.05.018_bib0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.suc.2020.12.012","article-title":"Cardiovascular risk reduction following metabolic and bariatric surgery","volume":"101","author":"Albaugh","year":"2021","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.ejim.2025.05.018_bib0011","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/oxfordjournals.aje.a008733","article-title":"How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?","volume":"143","author":"Gallagher","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0012","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev.nutr.17.1.527","article-title":"Human body composition: advances in models and methods","volume":"17","author":"Heymsfield","year":"1997","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.ejim.2025.05.018_bib0013","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/09637486.2017.1287884","article-title":"Validation of a literature-based adherence score to Mediterranean diet: the MEDI-LITE score","volume":"68","author":"Sofi","year":"2017","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.ejim.2025.05.018_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14029","article-title":"Ramadan intermittent fasting reduces visceral fat and improves gastrointestinal motility","volume":"53","author":"Abdallah","year":"2023","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2025.05.018_bib0015","doi-asserted-by":"crossref","unstructured":"Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640\u20135.","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"10.1016\/j.ejim.2025.05.018_bib0016","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0017","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.dld.2006.03.021","article-title":"The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis","volume":"38","author":"Palmentieri","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ejim.2025.05.018_bib0018","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s11548-018-1843-2","article-title":"Transfer learning with deep convolutional neural network for liver steatosis assessment in ultrasound images","volume":"13","author":"Byra","year":"2018","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"10.1016\/j.ejim.2025.05.018_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246837","article-title":"Hepatorenal index for grading liver steatosis with concomitant fibrosis","volume":"16","author":"Stahlschmidt","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2025.05.018_bib0020","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.12688\/f1000research.12170.1","article-title":"Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: a cross-sectional study in a Venezuelan population","volume":"6","author":"Salazar","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.ejim.2025.05.018_bib0021","doi-asserted-by":"crossref","DOI":"10.1007\/s42000-025-00634-6","article-title":"Development and validation of a new diagnostic prediction model for NAFLD based on machine learning algorithms in NHANES 2017-2020.3","author":"Wang","year":"2025","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.ejim.2025.05.018_bib0022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0023","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40842-024-00197-2","article-title":"Diagnostic accuracy of Fatty Liver Index (FLI) for detecting metabolic associated Fatty Liver Disease (MAFLD) in adults attending a tertiary care hospital, a cross-sectional study","volume":"10","author":"Vamja","year":"2024","journal-title":"Clin Diabetes Endocrinol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0024","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ejim.2025.05.018_bib0025","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","article-title":"Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease","volume":"23","author":"Min","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0026","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12933-022-01725-z","article-title":"The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study","volume":"21","author":"Park","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0027","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.clnu.2024.02.006","article-title":"Non-invasive tools for liver steatosis and steatohepatitis predict incidence of diabetes, cardiovascular disease and mortality 20 years later: the ATTICA cohort study (2002-2022)","volume":"43","author":"Kouvari","year":"2024","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ejim.2025.05.018_bib0028","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/dom.14950","article-title":"Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarction","volume":"25","author":"Chin","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ejim.2025.05.018_bib0029","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejim.2025.05.018_bib0030","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2024.03.017","article-title":"Metabolic dysfunction-associated fibrosis 5 (MAF-5) score predicts liver fibrosis risk and outcome in the general population with Metabolic dysfunction","volume":"167","author":"van Kleef","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2025.05.018_bib0031","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2025.05.018_bib0032","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejim.2024.04.013","article-title":"Metabolic dysfunction-associated steatotic liver disease: evolution of the final terminology","volume":"124","author":"Portincasa","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2025.05.018_bib0033","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102292","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study","volume":"65","author":"Moon","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejim.2025.05.018_bib0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12872-022-02601-0","article-title":"Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study","volume":"22","author":"Zibaeenejad","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ejim.2025.05.018_bib0036","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0735-1097(16)31843-5","article-title":"Validation of the atherosclerotic cardiovascular disease (ASCVD) pooled cohort risk equations by education level: the atherosclerosis risk in communities (ARIC) study","volume":"67","author":"Henderson","year":"2016","journal-title":"JACC"},{"key":"10.1016\/j.ejim.2025.05.018_bib0037","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijcard.2018.11.001","article-title":"External validation of two Framingham cardiovascular risk equations and the Pooled Cohort equations: a nationwide registry analysis","volume":"283","author":"Wallisch","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0038","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0039","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.05.018_bib0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4183\/aeb.2018.227","article-title":"Cardiovascular risk assessment in the adult (Aged 40-79 Years) Romanian population","volume":"14","author":"Rosu","year":"2018","journal-title":"Acta Endocrinol (Buchar)"},{"key":"10.1016\/j.ejim.2025.05.018_bib0041","unstructured":"Hintze J. NCSS 2023 Statistical Software (2023). NCSS, LLC. Kaysville, Utah, USA, ncss.com\/software\/ncss. Kaysville, Utah: Number Cruncher Statistical System (NCSS); 2023."},{"key":"10.1016\/j.ejim.2025.05.018_bib0042","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0043","article-title":"Gender differences in the epidemiology of alcohol use and related harms in the United States","volume":"40","author":"White","year":"2020","journal-title":"Alcohol Res"},{"key":"10.1016\/j.ejim.2025.05.018_bib0044","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a State-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.ejim.2025.05.018_bib0045","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s11739-023-03203-0","article-title":"NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care","volume":"18","author":"Portincasa","year":"2023","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ejim.2025.05.018_bib0046","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5009\/gnl19069","article-title":"Extrahepatic manifestations of nonalcoholic fatty liver disease","volume":"14","author":"Li","year":"2020","journal-title":"Gut Liver"},{"key":"10.1016\/j.ejim.2025.05.018_bib0047","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2025.05.018_bib0048","first-page":"e7948","article-title":"Assessment of obesity by using various anthropometric measurements among patients with coronary heart disease residing in North India","volume":"12","author":"Golia","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ejim.2025.05.018_bib0049","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5114\/ceh.2023.130744","article-title":"Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor","volume":"9","author":"Platek","year":"2023","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0050","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s00535-021-01828-6","article-title":"Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan","volume":"56","author":"Yoneda","year":"2021","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0051","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/apt.17637","article-title":"Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes","volume":"58","author":"Kuo","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2025.05.018_bib0052","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40545-023-00528-1","article-title":"A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study","volume":"16","author":"Zeitoun","year":"2023","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.ejim.2025.05.018_bib0053","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0054","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/liv.15939","article-title":"Impact of MASLD and MetALD on clinical outcomes: a meta-analysis of preliminary evidence","volume":"44","author":"Ciardullo","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2025.05.018_bib0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/HEP.0000000000000925","article-title":"MASLD\/MetALD and mortality in individuals with any cardio-metabolic risk factor: a population-based study with 26.7 years of follow-up","volume":"81","author":"Kwak","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2025.05.018_bib0056","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance","volume":"79","author":"Hutchison","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0057","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S2468-1253(23)00443-0","article-title":"Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study","volume":"9","author":"Israelsen","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155800","article-title":"Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: a community-dwelling cohort study with 20-year follow-up","author":"Choe","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.ejim.2025.05.018_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156101","article-title":"Prevalence, characteristics and outcomes of patients with metabolic and alcohol related\/associated liver disease (MetALD): a systematic review and meta-analysis","volume":"163","author":"Tampaki","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.ejim.2025.05.018_bib0060","first-page":"23","article-title":"Synergistic and detrimental effects of alcohol intake on progression of liver steatosis","author":"Di Ciaula","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejim.2025.05.018_bib0061","article-title":"Triglyceride glucose index: a new biomarker in predicting cardiovascular risk","volume":"29","author":"Araujo","year":"2022","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.ejim.2025.05.018_bib0062","doi-asserted-by":"crossref","DOI":"10.1007\/s10554-024-03193-w","article-title":"Association of subclinical carotid artery atherosclerosis assessed by carotid ultrasound with nonalcoholic fatty liver disease fibrosis score in young and middle-aged men","author":"Durak","year":"2024","journal-title":"Int J Cardiovasc Imag"},{"key":"10.1016\/j.ejim.2025.05.018_bib0063","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1007\/s10620-023-07987-1","article-title":"Fibrosis-4 index score predicts concomitant coronary artery diseases across the spectrum of fatty liver disease","volume":"68","author":"McNally","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejim.2025.05.018_bib0064","first-page":"1","article-title":"Noninvasive liver fibrosis markers are independently associated with carotid atherosclerosis risk in patients with nonalcoholic fatty liver disease","author":"Su","year":"2024","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0065","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-024-10798-1","article-title":"Liver fibrosis is associated with left ventricular remodeling: insight into the liver-heart axis","author":"Edin","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejim.2025.05.018_bib0066","doi-asserted-by":"crossref","first-page":"e2102","DOI":"10.1002\/hsr2.2102","article-title":"The correlation between liver fibrosis and the 10-year estimated risk of cardiovascular disease in adults with metabolic-associated fatty liver disease: a cross-sectional study in Vietnam","volume":"7","author":"Dang","year":"2024","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.ejim.2025.05.018_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.03.045","article-title":"Liver fibrosis assessed via noninvasive tests is associated with incident heart failure in a general population cohort","author":"Hydes","year":"2024","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525002122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525002122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:14:48Z","timestamp":1762337688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525002122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":67,"alternative-id":["S0953620525002122"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.05.018","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic dysfunction-associated steatotic liver disease (MASLD). Assessing metabolic dysfunction, cardiovascular risk factors, and lifestyle habits","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}